BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gąsowski J, Piotrowicz K. Hypertension in the elderly: Change of, or new implications within the existing, paradigm? European Geriatric Medicine 2017;8:289-92. [DOI: 10.1016/j.eurger.2017.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Fernández-Llama P, Ayasreh N, Calero F. [Hypertension in the elderly: What we need to know]. Hipertens Riesgo Vasc 2021;38:91-8. [PMID: 33239263 DOI: 10.1016/j.hipert.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Bhat ZF, Mason S, Morton JD, Bekhit AEA, Bhat HF. Antihypertensive Peptides from Animal Proteins. Bioactive Molecules in Food 2019. [DOI: 10.1007/978-3-319-78030-6_18] [Reference Citation Analysis]
3 Bhat ZF, Mason S, Morton JD, Bekhit AEA, Bhat HF. Antihypertensive Peptides from Animal Proteins. Reference Series in Phytochemistry 2018. [DOI: 10.1007/978-3-319-54528-8_18-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Strandberg T, Benetos A. Successful SPRINT hypertension trial does not cover all older patients. European Geriatric Medicine 2017;8:279-80. [DOI: 10.1016/j.eurger.2017.05.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]